Cargando…
Improved adherence adjustment in the Coronary Drug Project
BACKGROUND: The survival difference between adherers and non-adherers to placebo in the Coronary Drug Project has been used to support the thesis that adherence adjustment in randomized trials is not generally possible and, therefore, that only intention-to-treat analyses should be trusted. We previ...
Autores principales: | Murray, Eleanor J., Hernán, Miguel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836455/ https://www.ncbi.nlm.nih.gov/pubmed/29506561 http://dx.doi.org/10.1186/s13063-018-2519-5 |
Ejemplares similares
-
Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study
por: Young, Jessica G., et al.
Publicado: (2019) -
Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data
por: Hellier, Jennifer, et al.
Publicado: (2020) -
Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate “normative adherence”
por: Hoo, Zhe Hui, et al.
Publicado: (2016) -
Adjusting microbiome profiles for differences in microbial load by spike-in bacteria
por: Stämmler, Frank, et al.
Publicado: (2016) -
Adjusting wheal size measures to correct atopy misclassification
por: Zhang, Hongmei, et al.
Publicado: (2011)